# BEXAROTENE
> **ANDA210352** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2024-12-10
## Drug
- **FDA Application Number:** ANDA210352
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BEXAROTENE
- **Generic name:** Bexarotene
- **Active ingredients:** BEXAROTENE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CIPLA
- **First approval:** 2024-12-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210352)
---
*AI Analytics · CC0 1.0*